Accreditation/Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 30.0 Contact Hours.
Mini Symposium: Designated for a maximum of 3.75 AMA PRA Category 1 Credits™ (3.75 Contact Hours)
Main Symposium: Designated for a maximum of 26.25 AMA PRA Category 1 Credits™ (26.25 Contact Hours)
This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org/
Acknowledgment of Commercial Support
This activity is supported by educational grants from AbbVie, Acelity, Astellas, AstraZeneca, Celgene, Eisai Inc., Genentech, Inc., Genomic Health, Inc., Lilly, Novartis Pharmaceuticals Corporation, Pacira Pharmaceuticals, Inc., Pfizer, Puma Biotechnology, Inc, and TESARO, Inc.
For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
33rd Annual Miami Breast Cancer Conference®
Click here to download brochure
Fontainebleau Miami Beach
4441 Collins Avenue
Miami Beach, FL 33140
The overriding theme of the Miami Breast Cancer Conference®, "Hear it on Friday, use it on Monday", continues to be embraced by the Chairs of the conference. Indeed, at the 33rd Annual Miami Breast Cancer Conference®, attendees will not only improve their knowledge of novel treatment approaches, but also leave the conference with the confidence and intent to apply state-of-the-art treatment strategies to care for their patients with breast cancer.
The multidisciplinary Miami Breast Cancer Conference® has a tremendous legacy to bring together key disciplines from medical, surgical, and radiation oncology, as both faculty and attendees. International experts continue to serve as faculty for this premier and internationally renowned oncology conference, which focuses on the most relevant breast cancer topics during General Sessions, Medical and Surgical Tracked Sessions, Tumor Boards, and the popular Medical Crossfire® Sessions.
Target AudienceThis educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
Mini-SymposiumThe 33rd Annual Miami Breast Cancer Conference® Mini-Symposium offers an additional educational opportunity for attendees who plan to arrive in Miami the day before the official conference begins. The Mini-Symposium takes the format of a World-Class Tumor Board, featuring cases and discussions that highlight challenging clinical situations commonly faced by surgeons and oncologists, including:
- The value of excision when LCIS is found at core needle biopsy
- Breast-conservation therapy by tumor biologic subtype
- The challenge of pain management
- Defining and managing invasive lobular carcinoma
- Regional node irradiation in sentinel node-positive disease
- Contemporary issues in lymphedema
- Therapy for intermediate-risk ER-positive, HER2-negative tumors
- And more...
Note: Separate registration is required.
Save the Date
• March 9-12, 2017
Program ChairPatrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Program DirectorsJ. Michael Dixon, MD
Consultant Breast Surgeon, Western General Hospital
Clinical Director, Breakthrough Breast Cancer Research Unit in Edinburgh
Honorary Professorship in Breast Surgery, University of Edinburgh
Hyman B. Muss, MD
Professor of Medicine
University of North Carolina School of Medicine
Mary Jones Hudson Distinguished Professor of Geriatric Oncology
Director, Geriatric Oncology Program
UNC-Lineberger Comprehensive Cancer Center Program
Chapel Hill, NC
Debu Tripathy, MD
Professor and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Amy Robach was named News Anchor for ABC’s Good Morning America; in March 2014. Since joining ABC News, Robach has traveled nationally and internationally to cover major news events. She traveled to Nigeria to interview Malala Yousafzai, the seventeen year-old who was in the African country as part of a campaign to free hundreds of captive school girls. Robach reported live from South Africa just days after the shooting of Oscars Pistorious’ girlfriend Reeva Steenkamp, and anchored a special 20/20: The Fast Times of Oscar Pistorius. She also anchored ABC News’ coverage of the 2014 Winter Olympics in Sochi, Russia and reported from London for the birth of Prince George. Breaking news stories in the U.S. Robach has covered include: Superstorm Sandy, reporting live from the Rockaways on the one-year anniversary; and the Sandy Hook Elementary School shooting in Newtown, Connecticut. Additionally, she sat down with recording pop star Taylor Swift after her worldwide exclusive live-stream on Yahoo and ABC News announcing Swift’s new album and single.
You must be logged in to PER to register for this meeting
Or Register for PER now
In case of onsite emergency:
Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19
I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventive measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities, including providing proof at check in of being 2 weeks removed from receiving a full COVID-19 vaccination or results from a negative COVID-19 viral test taken no more than 3 days prior to the program.
I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.
* By checking this box, you have read and understand the above and agree to its terms.